Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Clinical outcomes and risk factors of culture negative infectious scleritis
Author Affiliations & Notes
  • Aravind Roy
    Cornea and Anterior Segment Services, LV Prasad Eye Institute Kode Venkatadri Chowdary Campus, Vijayawada, Andhra Pradesh, India
  • Joveeta Joseph Ruben
    Cornea and Anterior Segment Services, LV Prasad Eye Institute, Hyderabad, Telangana, India
    Jhaveri Microbiology Center, LV Prasad Eye Institute, Hyderabad, Telangana, India
  • Jamema Dada Be Shaik
    Cornea and Anterior Segment Services, LV Prasad Eye Institute Kode Venkatadri Chowdary Campus, Vijayawada, Andhra Pradesh, India
  • Arpita Khasnavis
    Cornea and Anterior Segment Services, LV Prasad Eye Institute, Hyderabad, Telangana, India
  • Somasheila I Murthy
    Cornea and Anterior Segment Services, LV Prasad Eye Institute, Hyderabad, Telangana, India
    Cornea and Anterior Segment Services, Shantilal Shangvi Eye Institute, Mumbai, Maharashtra, India
  • Footnotes
    Commercial Relationships   Aravind Roy None; Joveeta Joseph Ruben None; Jamema Dada Be Shaik None; Arpita Khasnavis None; Somasheila Murthy None
  • Footnotes
    Support  Hyderabad Eye Research Foundation
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 1097. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Aravind Roy, Joveeta Joseph Ruben, Jamema Dada Be Shaik, Arpita Khasnavis, Somasheila I Murthy; Clinical outcomes and risk factors of culture negative infectious scleritis. Invest. Ophthalmol. Vis. Sci. 2024;65(7):1097.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Culture negative (CN) infectious scleritis is not a well described entity in ophthalmic literature. We conducted a retrospective comparative clinical study of culture positive (CP) and culture negative infectious scleritis to ascertain the risk factors and clinical outcomes of culture negative infectious scleritis.

Methods : We reviewed medical records of infectious scleritis. Scleral lesions were deemed as infectious on clinical appearance of boggy, purulent exudates, with or without ulceration, scleral abscess, and presence of hypopyon. Scleral debridement and microbiologic evaluation were done. Scrapings were repeated if the initial sample was negative. Treatment was started with empirical antibiotics, change to specific class of drugs, depending on type of organisms isolated. Topical or oral steroids were prescribed on case-to-case basis. Scleritis was resolved if there were no symptoms, lack of ocular inflammation, quiet eye with or without scleral thinning and uveal show. Mann-Whitney U test and Wilcoxon signed rank test was used to compare continuous variables within two groups. Logistic regression was used to calculate crude odds ratio (crude OR). P value < 0.05 was considered statistically significant.

Results : We included 147 eyes of 147 patients of infectious scleritis between Jan 2006 to December 2022 of which 98 eyes were CP and 49 eyes were CN. Gram negative bacteria were the most common isolated organisms (n=27/98). Baseline demographics of age, gender, agriculture work, ocular trauma, and prior ocular surgeries between two groups were comparable. Diabetics were 2.85 times more likely to be CP (crude OR= 2.85; 95% CI: 1.02 to 8.02). Treatment with prior steroids were 68% less likely to be CP (crude OR= 0.32; 95% CI: 0.13 to 0.76). Median presenting and final visual acuity was significantly lower in CP as compared to CN scleritis (p<0.001). There was no difference in duration of symptoms, treatment and time to resolution between two groups. Odds of recurrence were 94.9% lesser in CP as compared to CN scleritis (crude OR= 0.051; 95% CI: 0.003 to 0.974).

Conclusions : Culture negative scleritis accounted for a third of infectious scleritis. Nondiabetics and treatment with prior steroids were risk factors. Visual acuity was better in CN but clinical outcomes was comparable between two groups. Chance of recurrence was more in CN scleritis.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×